Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Vaccine
|
March 21, 2001
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
A Podda
Vaccine
|
October 6, 2001
What are the limits of adjuvanticity?
G Del Giudice, A Podda, R Rappuoli
Clinical Pharmacology and Therapeutics
|
November 1, 2007
MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?
D T O'Hagan, A Wack, A Podda
Advances in Experimental Medicine and Biology
|
January 1, 1991
Genetic approaches to a vaccine for pertussis
L Nencioni, M Pizza, G Volpini, et al.
Developments in Biological Standardization
|
December 17, 1998
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination
P Olin, H O Hallander, L Gustafsson, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Interaction between deletion delta-thalassemia and beta zero-thalassemia (codon 39 nonsense mutation) in a Sardinian family
R Galanello, A Podda, M A Melis, et al.
The European Respiratory Journal
|
March 1, 1991
Protective effect and duration of action of formoterol aerosol on exercise-induced asthma
A Patessio, A Podda, M Carone, et al.
Trends in Biotechnology
|
July 1, 1991
Towards third-generation whooping cough vaccines
R Rappuoli, M Pizza, A Podda, et al.
Diagnostic and Interventional Imaging
|
April 3, 2019
Posterior interosseous nerve of the elbow at the arcade of Frohse: Ultrasound appearance in asymptomatic subjects
T Ceri, A Podda, J Behr, et al.
Vaccine
|
January 1, 1993
Absence of protective immunity against diphtheria in a large proportion of young adults
R Rappuoli, A Podda, F Giovannoni, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Vaccine
|
March 21, 2001
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
A Podda
Vaccine
|
October 6, 2001
What are the limits of adjuvanticity?
G Del Giudice, A Podda, R Rappuoli
Clinical Pharmacology and Therapeutics
|
November 1, 2007
MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?
D T O'Hagan, A Wack, A Podda
Advances in Experimental Medicine and Biology
|
January 1, 1991
Genetic approaches to a vaccine for pertussis
L Nencioni, M Pizza, G Volpini, et al.
Developments in Biological Standardization
|
December 17, 1998
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination
P Olin, H O Hallander, L Gustafsson, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Interaction between deletion delta-thalassemia and beta zero-thalassemia (codon 39 nonsense mutation) in a Sardinian family
R Galanello, A Podda, M A Melis, et al.
The European Respiratory Journal
|
March 1, 1991
Protective effect and duration of action of formoterol aerosol on exercise-induced asthma
A Patessio, A Podda, M Carone, et al.
Trends in Biotechnology
|
July 1, 1991
Towards third-generation whooping cough vaccines
R Rappuoli, M Pizza, A Podda, et al.
Diagnostic and Interventional Imaging
|
April 3, 2019
Posterior interosseous nerve of the elbow at the arcade of Frohse: Ultrasound appearance in asymptomatic subjects
T Ceri, A Podda, J Behr, et al.
Vaccine
|
January 1, 1993
Absence of protective immunity against diphtheria in a large proportion of young adults
R Rappuoli, A Podda, F Giovannoni, et al.
Page
of 6